Results 1-10 of approx. 392

BioMarin Pharmaceuticals Inc (BMRN) Stock Quote

Get the latest BMRN - BioMarin Pharmaceuticals Inc stock market performance data and financial news.

http://www.thestreet.com/quote/BMRN.html

BioMarin Pharmaceuticals Inc (BMRN) Community Sentiment ...

Get the latest BMRN - BioMarin Pharmaceuticals Inc together with stock market performance data and financial news.

http://www.thestreet.com/quote/BMRN/details/sentiment.html

BioMarin Pharmaceuticals Inc (BMRN) Stock Quote

Get the latest BMRN - BioMarin Pharmaceuticals Inc stock market performance data and financial news.

http://www.thestreet.com/quote/BMRN/real-time-news.html

Jim Cramer's Take on BioMarin Pharmaceuticals Inc

Read Jim Cramer's take on BioMarin Pharmaceuticals Inc (BMRN) and get his latest thoughts on the company?s performance and outlook

http://www.thestreet.com/cramerstake/BMRN.html

RealMoney.com: Today's Short-Squeeze Plays: BMRN

Today's Short-Squeeze Plays: BMRN, As the stock closes in on its
52-week high, a potential short squeeze is on the doorstep. ...

http://www.thestreet.com/p/rmoney/biotech/10396163.html

Financial Portfolio on Recent Stock Quotes & Stock Market Picks ...

Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.

http://www.thestreet.com/earnings/BMRN/

BioMarin Swings to a Loss in First Quarter

By Scott Eden 04/30/09

BioMarin posts a first-quarter loss on markdowns of two investments; revenue jumps 23%.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10494707/1/biomarin-swings-to-a-loss-in-first-quarter.html

Analysts' Upgrades, Downgrades: HP

By TSC Staff 02/19/09

See who made what calls.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10464777/1/analysts-upgrades-downgrades-h-p.html

BioMarin Buys Rights to Long-Delayed La Jolla Drug

By Adam Feuerstein 01/06/09

The company has licensed worldwide commercial rights to Riquent, an experimental lupus drug from La Jolla Pharmaceuticals.. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10456368/1/biomarin-buys-rights-to-long-delayed-la-jolla-drug.html

Psst... These Drug Firms Are Getting Bought: BioBuzz

By Adam Feuerstein 09/17/09

Big Pharma is seeking deals with biotech, specialty pharma, analyst says. Check out TheStreet for the latest stock market news and financial investment headlines.

http://www.thestreet.com/story/10599708/1/psst-these-drug-firms-are-getting-bought-biobuzz.html

More From TheStreet

Latest Headlines

Brokerage Partners

TheStreet Premium Services

All Services